PFKM Polyclonal Antibody, 100ul Endonucleases & Exonucleases LPPs catalyze the dephosphorylation of

LPPs catalyze the dephosphorylation of a number of bioactive lipid mediators that regulate a variety of cell functions

subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus

L-alanine is transported at physiological concentrations

characterized by the co-occurrence of Sick Sinus Syndrome (SSS) and Chronic Intestinal Pseudo-obstruction (CIPO) within the first four decades of life (PMID: 25282101)

and activated aflatoxin B1 as substrates

PFKM Polyclonal Antibody, 100ul Endonucleases & Exonucleases LPPs catalyze the dephosphorylation ofThree phosphofructokinase isozymes exist in humans: muscle, liver and platelet. These isozymes function as subunits of the mammalian tetramer phosphofructokinase, which catalyzes the phosphorylation of fructose 6 phosphate to fructose 1,6 bisphosphate. Tetramer composition varies depending on tissue type. PFKM encodes the muscle type isozyme. Mutations in PFKM have been associated with glycogen storage disease type VII, also known as Tarui disease.